Myriad Genetics, Inc.

AGTANALYSIS

AGT ANALYSIS;medical and genetic testing services, namely, providing testing services directed to identifying gene mutation likely to increase and individual's risk of hypertension;

AMPLIFY

Genetic testing with cell-free DNA for medical purposes;

AP

genetic testing services;

BE READY AGAINST CANCER

genetic testing services;

BRACANALYSIS

medical test kits, comprising test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, used in connection with the detection of gene mutations associated with breast, ovarian, and pancreatic cancers;medical tests, namely, providing reference and clinical laboratory tests which detect gene mutations associated with breast, ovarian, and pancreatic cancers;

BRACANALYSIS CDX

BRAC ANALYSIS CDX;Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers to evaluate and select therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens and identifying molecular profiles associated with successful therapies or treatment regimens; medical testing services for evaluating the efficacy or toxicity of medical treatments;Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for the detection of gene mutations, gene expression profiles or other molecular indicators or markers for use in evaluating and selecting therapy or treatment regimen;CDX;

BRACAONE

medical test kits, comprising test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, used in connection with the detection of gene mutations associated with breast, ovarian, and pancreatic cancers;medical tests, namely, providing reference and clinical laboratory tests which detect gene mutations associated with breast, ovarian, and pancreatic cancers;

BRACATWO

medical test kits, comprising test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, used in connection with the detection of gene mutations associated with breast, ovarian, and pancreatic cancers;medical tests, namely, providing reference and clinical laboratory tests which detect gene mutations associated with breast, ovarian, and pancreatic cancers;

CARDIARISK

CARDIOVASCULAR RISK;genetic testing services in connection with cardiovascular diseases and hypertension;

CCP PANEL

medical diagnostic and prognostic testing, namely, providing clinical laboratory tests which detect molecular abnormalities associated with cancer;PANEL;

CCP SCORE

medical diagnostic and prognostic testing namely, providing clinical laboratory tests which detect molecular abnormalities associated with cancer;SCORE;

CCP SIGNATURE

medical diagnostic and prognostic testing, namely, providing clinical laboratory tests which detect molecular abnormalities associated with cancer;

COLARIS

genetic testing services;

COLARIS AP

genetic testing services;

COMPARECALLS

COMPARE CALLS;medical laboratory services in the field of genetic profiling; and laboratory research in the field of genetic profiling;

CUSTOMMAP

CUSTOM MAP;Customizable biochemical analysis services, namely, evaluation of non-genetic biological response to disease, drugs and the environment;

E-CODIS

E CODIS;genetic testing services;

FIRSTGENE

FIRST GENE;Nucleic acid screening for medical purposes, namely, prenatal carrier screening services, non-invasive prenatal screening services;

FIRSTGENE

FIRST GENE;Specimen collection kits for use in nucleic acid screening for medical purposes comprised primarily of blood collection tubes for medical samples, printed vial labels, testing instructions, and mailing containers;

HEALTH. ILLUMINATED.

Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagents, assays, chemical preparations, and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditions, disorders, and diseases for medical use;Genetic testing services for diagnostic or treatment purposes; genetic testing for medical purposes; genetic counseling; diagnostic services in the field of genetics, namely, the identification of genes that predispose individuals to common diseases and health disorders for diagnostic or treatment purposes; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disease severity, identifying predisposition to developing disease, evaluating the efficacy or toxicity of medical treatments, and identifying risk factors of disease, molecular profiles associated with successful therapies or treatment regimens, and for classifying disease progression or severity; medical diagnostic testing, monitoring, and reporting services; internet-based health care information services; providing an internet website for medical professionals featuring medical information in the field of hereditary cancer risk assessment and testing; providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment, drug, and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis and medical and pharmaceutical consultation services related thereto, namely, discussion and interpretation with clients of medical test results and medical analysis related thereto; medical testing services, namely, providing medical tests that measure, analyze, and interpret genes and medications of patients, environmental, and other factors through an algorithm that weighs the contribution of each medication's multiple pathways of absorption, distribution, metabolism, and excretion and each medication's receptor activity, mechanism of action, and pathways of response and then measures the impact of genomic changes across these pathways and across multiple of patients to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection, and treatment options and choices for patients, identify potentially harmful drug interactions, and calculate drug dosage adjustments for patients; and medical information services, namely, preparation and generation of reports for the foregoing medical testing services through proprietary software applications; medical analysis and consultation services which use bioinformatics for diagnostic or treatment purposes; providing objective, evidence-based medical information tailored to each patient's individual genetic profile to enable clinicians to prescribe individually appropriate medications;Medical test kits comprising specimen collection tubes and containers for collecting patient specimens, printed test forms, printed mailing materials, and printed user information inserts used in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; sample preparation device for medical diagnostic uses; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of tissue-based diagnostic testing, cytology and cell-based testing; blood, urine, and saliva medical specimen collection kits consisting of test tubes and self-mailer, used for health and genetic analysis and diagnostics;HEALTH;Clinical research in the field of genetics directed to the evaluation of genetic variants; clinical research in human genetics; statistical analysis relating to scientific research in the field of human genetics and genetic variation; design and development of statistical algorithms for use in the field of human genetics and evaluation of genetic variations; statistical analysis for determining deleterious genetic variations in the field of human genetics, for scientific research purposes; clinical trial research and laboratory research services for the further purpose of drug discovery services, pharmaceutical research services, pre-clinical medical research screening, and clinical trial, research and evaluation services; biosignatures, genomics, proteomics and pharmacology research services; development of disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening for scientific research purposes, pre-clinical research and trials for pharmaceutical development purposes; and research and development of new diagnostic products and pharmaceutical drug services for others; biochemical analysis services, namely, evaluation of non-genetic biological response to disease, drugs, and the environment; providing temporary use of non-downloadable computer software for customizing, selecting, and ordering health and genetic analysis and diagnostic kits and assays and for accessing, viewing, and storing health and genetic information via electronic, optical, and wireless communication networks; scientific research analysis and consulting services which use bioinformatics; gene and tissue bank services that provide DNA samples for use in future medical and scientific research, medical and scientific educational studies and development of new medical and scientific products and validation thereof;

HRD

Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers to evaluate and select therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens and identifying molecular profiles associated with successful therapies or treatment regimens; medical testing services for evaluating the efficacy or toxicity of medical treatments;Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for the detection of gene mutations, gene expression profiles or other molecular indicators or markers for use in evaluating and selecting therapy or treatment regimen;

M-CO

Medical genetic testing, namely, providing evaluation of genetic variants; genetic testing for medical purposes featuring genetic and statistical analysis relating to gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease; medical testing services for diagnostic or treatment purposes for predicting disease and identifying risk factors of disease;

M-CO SCORE

Medical genetic testing, namely, providing evaluation of genetic variants; genetic testing for medical purposes featuring genetic and statistical analysis relating to gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease; medical testing services for diagnostic or treatment purposes for predicting disease and identifying risk factors of disease;SCORE;

MTSANALYSIS

MTS ANALYSIS;medical and genetic testing services, namely, providing testing services directed to identifying gene mutations likely to increase an individual's susceptibility to melanoma;

MYCHOICE

MY CHOICE;Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers to evaluate and select therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens and identifying molecular profiles associated with successful therapies or treatment regimens; medical testing services for evaluating the efficacy or toxicity of medical treatments;Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for the detection of gene mutations, gene expression profiles or other molecular indicators or markers for use in evaluating and selecting therapy or treatment regimens;

MYGENEHISTORY

MY GENE HISTORY;Medical diagnostic screening and analysis for the treatment of persons; predictive medical analysis services relating to the selection of treatments for cancer; medical screening services in the field of cancer; Providing information to patients in the field of medical diagnostic screening; health evaluation; health assessment services; Providing online publications, namely, questionnaires for medical screening for diagnostic or treatment purposes; providing medical information; providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing; providing genetic testing for medical purposes; Providing on-line information regarding the clinical and treatment use of downloadable screening questionnaires in the field of oncology;Providing temporary use of non-downloadable software for use in medical screening for diagnostic or treatment purposes; Software as a service (SAAS) services featuring software for use in medical screening for diagnostic or treatment purposes;

MYPATH

MY PATH;Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers to diagnose or classify disease; medical testing services for diagnosing or classifying disease and identifying molecular profiles of disease;Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for detection of gene mutations, gene expression profiles or other molecular indicators or markers for use in diagnosing or classifying disease;

MYPLAN

MY PLAN;Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers to prognose disease or predict disease progression or disease severity; medical testing services for prognosing disease or predicting disease progression or disease severity and identifying molecular profiles for classifying disease progression or severity;Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for detection of gene mutations, gene expression profiles or other molecular indicators or markers for use in prognosing disease or predicting disease progression or disease severity;

MYRIAD

diagnostic services in the field of genetics, namely the identification of genes that predispose individuals to common diseases and health disorders;

MYRIAD GENETICS

The mark consists of the word MYRIAD with the M appearing as a capital letter formed by four (4) lines that do not touch, and the remainder of the word appearing in lowercase letters, and the word GENETICS directly below MYRIAD appearing in lowercase letters.;Genetic testing services for diagnostic or treatment purposes; genetic testing for medical purposes; genetic counseling; diagnostic services in the field of genetics, namely, the identification of genes that predispose individuals to common diseases and health disorders for diagnostic or treatment purposes; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disease severity, identifying predisposition to developing disease, evaluating the efficacy or toxicity of medical treatments, and identifying risk factors of disease, molecular profiles associated with successful therapies or treatment regimens, and for classifying disease progression or severity; medical diagnostic testing, monitoring, and reporting services; internet-based health care information services; providing an internet website for medical professionals featuring medical information in the field of hereditary cancer risk assessment and testing; providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment, drug, and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis and medical and pharmaceutical consultation services related thereto, namely, discussion and interpretation with clients of medical test results and medical analysis related thereto; medical testing services, namely, providing medical tests that measure, analyze, and interpret genes and medications of patients, environmental, and other factors through an algorithm that weighs the contribution of each medication's multiple pathways of absorption, distribution, metabolism, and excretion and each medication's receptor activity, mechanism of action, and pathways of response and then measures the impact of genomic changes across these pathways and across multiple of patients to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection, and treatment options and choices for patients, identify potentially harmful drug interactions, and calculate drug dosage adjustments for patients; and medical information services, namely, preparation and generation of reports for the foregoing medical testing services through proprietary software applications; medical analysis and consultation services which use bioinformatics for diagnostic or treatment purposes; providing objective, evidence-based medical information tailored to each patient's individual genetic profile to enable clinicians to prescribe individually appropriate medications;GENETICS;Clinical research in the field of genetics directed to the evaluation of genetic variants; clinical research in human genetics; statistical analysis relating to scientific research in the field of human genetics and genetic variation; design and development of statistical algorithms for use in the field of human genetics and evaluation of genetic variations; statistical analysis for determining deleterious genetic variations in the field of human genetics, for scientific research purposes; clinical trial research and laboratory research services for the further purpose of drug discovery services, pharmaceutical research services, pre-clinical medical research screening, and clinical trial, research and evaluation services; biosignatures, genomics, proteomics and pharmacology research services; development of disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening for scientific research purposes, pre-clinical research and trials for pharmaceutical development purposes; and research and development of new diagnostic products and pharmaceutical drug services for others; biochemical analysis services, namely, evaluation of non-genetic biological response to disease, drugs, and the environment; providing temporary use of non-downloadable computer software for customizing, selecting, and ordering health and genetic analysis and diagnostic kits and assays and for accessing, viewing, and storing health and genetic information via electronic, optical, and wireless communication networks; scientific research analysis and consulting services which use bioinformatics; gene and tissue bank services that provide DNA samples for use in future medical and scientific research, medical and scientific educational studies and development of new medical and scientific products and validation thereof;